Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.18T
Market cap1.18T
Price-Earnings ratio
42.28
Price-Earnings ratio42.28
Dividend yield
0.52%
Dividend yield0.52%
Average volume
2.56M
Average volume2.56M
High today
$1,271.22
High today$1,271.22
Low today
$1,230.00
Low today$1,230.00
Open price
$1,230.71
Open price$1,230.71
Volume
1.62M
Volume1.62M
52 Week high
$1,292.65
52 Week high$1,292.65
52 Week low
$694.23
52 Week low$694.23

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,255.21, giving the company a market capitalization of 1.18T. It carries a P/E multiple of 42.28 and pays a dividend yield of 0.52%.

On 2026-08-21, Eli Lilly(LLY) stock traded between a low of $1,230.00 and a high of $1,271.22. Shares are currently priced at $1,255.21, which is +2.0% above the low and -1.3% below the high.

The Eli Lilly(LLY)'s current trading volume is 1.62M, compared to an average daily volume of 2.56M.

During the past year, Eli Lilly(LLY) stock moved between $694.23 at its lowest and $1,292.65 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $694.23 at its lowest and $1,292.65 at its peak.

LLY News

TipRanks 3h
Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

TipRanks 3h
Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

TipRanks 3h
Eli Lilly Completes Mid-Stage Hidradenitis Suppurativa Trial, Adding Depth to Its Immunology Pipeline

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
12.1%
Sell
6.1%

More LLY News

TipRanks 3h
Eli Lilly’s LOXO-260 Trial Completion: What It Means for RET-Targeted Cancer Investing

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

Simply Wall St 4h
Absci Following Phase 1 Data And Lilly Backing Still Looks Undervalued

Absci (ABSI) is back in focus after interim Phase 1 data for its ABS-201 program indicated favorable safety, tolerability, and pharmacokinetics, along with a re...

Absci Following Phase 1 Data And Lilly Backing Still Looks Undervalued
Nasdaq 5h
Stock Split Watch: Is Eli Lilly Stock Next?

Key Points The public doesn't know when, or if, an Eli Lilly split is happening soon. It doesn't really matter, though, since splits are largely nonevents. S...

Stock Split Watch: Is Eli Lilly Stock Next?
Investor's Business Daily 7h
Tesla, Waymo, Uber Granted Las Vegas Robotaxi Permits

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Eli Lilly Tops Buy Point 8/21/2026 Among the best stocks in earnings performance, highly...

Tesla, Waymo, Uber Granted Las Vegas Robotaxi Permits
TipRanks 9h
Eli Lilly Buy Rating Reiterated on Durable Incretin and Obesity Growth, Price Target Maintained at $1,344

Analyst Jason Gerberry from Bank of America Securities maintained a Buy rating on Eli Lilly & Co and keeping the price target at $1,344.00. Unlock powerful inv...

Investor's Business Daily 1d
Deere Soars: Energy Infrastructure, Data Centers Fuel (At Last) An Earnings Gain

Stocks To Watch: 14 Names Test And Tease New Buy Zones 7/08/2026 A barrage of stocks to watch like Eli Lilly and Deere, show promise, alongside reminders to ke...

Deere Soars: Energy Infrastructure, Data Centers Fuel (At Last) An Earnings Gain
TipRanks 1d
Lilly’s Mirikizumab Breast Milk Study Adds A New Layer To Immunology Safety Data

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.